1. Home
  2. STEX vs RFL Comparison

STEX vs RFL Comparison

Compare STEX & RFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

STEX

Streamex Corp.

HOLD

Current Price

$0.80

Market Cap

86.3M

Sector

N/A

ML Signal

HOLD

Logo Rafael Holdings Inc. Class B

RFL

Rafael Holdings Inc. Class B

HOLD

Current Price

$2.76

Market Cap

92.6M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
STEX
RFL
Founded
2009
2017
Country
United States
United States
Employees
6
N/A
Industry
Real Estate
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
86.3M
92.6M
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
STEX
RFL
Price
$0.80
$2.76
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$9.00
N/A
AVG Volume (30 Days)
1.4M
274.0K
Earning Date
05-17-2026
06-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
28.28
EPS
N/A
N/A
Revenue
N/A
$917,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$1,044.81
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
43.96
52 Week Low
$0.70
$1.12
52 Week High
$7.44
$2.95

Technical Indicators

Market Signals
Indicator
STEX
RFL
Relative Strength Index (RSI) 38.96 73.51
Support Level $0.70 $1.22
Resistance Level $1.12 N/A
Average True Range (ATR) 0.10 0.32
MACD -0.03 0.06
Stochastic Oscillator 21.74 81.75

Price Performance

Historical Comparison
STEX
RFL

About STEX Streamex Corp.

Streamex Corp is a vertically integrated technology and infrastructure company. The Company is a technology company with two principal lines of business: (i) Tokenized Asset Finance, focused on digital asset and real-world asset tokenization via Streamex Exchange platform, and (ii) Biomedical Technology, focused on signal processing solutions in electrophysiology. The group provides institutional-grade solutions that bring traditional commodities and assets on-chain through secure, regulated, and yield-bearing financial instruments. It is committed to delivering transparent, scalable, and compliant digital asset solutions that bridge the gap between traditional finance and blockchain-enabled markets.

About RFL Rafael Holdings Inc. Class B

Rafael Holdings Inc is a biotechnology firm that develops pharmaceuticals and invests in clinical and early-stage companies in pharmaceuticals and medical devices. Trappsol Cyclo is in Phase 3 trials for Niemann-Pick Disease Type C1. The company focuses on completing these trials, seeking regulatory approval, and commercializing the product. It also invests in portfolio companies including Cyclo, LipoMedix, Barer, Rafael Medical Devices, Cornerstone, and Day Three, targeting therapeutics for unmet medical needs. The business operates through three segments: Healthcare, Infusion Technology, and Real Estate. Operations are based in the United States and Israel.

Share on Social Networks: